Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 9, 2018
Distillery Techniques

Drug platforms

BioCentury | Aug 18, 2017
Emerging Company Profile

Teasing out Th1

EpiThany's strategy for creating more potent therapeutic cancer vaccines
BioCentury | Mar 23, 2015
Finance

Alize's assets

How Alize Pharma is using an asset-centric model to maximize capital efficiency
BioCentury | Dec 15, 2014
Company News

New Paradigm Therapeutics, Alize Pharma deal

BioCentury | Jun 12, 2014
Distillery Therapeutics

Indication: Cancer

BioCentury | Mar 6, 2014
Cover Story

Liver X receptor marks the spot

BioCentury | Feb 23, 2012
Distillery Therapeutics

Indication: Cancer

Items per page:
1 - 10 of 14